Présentation
David Revcolevschi intervient principalement dans le cadre d’opérations de marchés des capitaux et de fusions-acquisitions en France et à l’international et plus généralement sur tout ce qui concerne la vie et la gouvernance des sociétés cotées.
David dispose également d’une très grande expérience dans le domaine des émissions de valeurs mobilières en qualité de conseil des émetteurs, des banques ou des actionnaires. Il est intervenu comme conseil sur plus de 30 projets d’introductions en bourse (IPO) ainsi que sur de nombreuses autres opérations d’émissions d’actions ou de titres donnant accès au capital réalisées par des sociétés opérant dans des secteurs variés tels que sciences de la vie (biotechnologie, dispositifs médicaux), technologies, logiciels, services informatiques, opérateurs télécoms, transport aérien, construction aéronautique, immobilier, loisirs, cosmétiques, chimie, infrastructures, fonds ou institutions financières. Il intervient également dans des contentieux de sanctions mettant en cause émetteurs ou leurs dirigeants et salariés devant l’Autorité des marchés financiers.
Son expérience de transactions à la fois dans un cadre français et international lui permet de concilier les différences entre parties de cultures différentes dans le cadre d’opérations transfrontalières et internationales souvent complexes. Il conseille les sociétés cotées et privées sur leurs acquisitions, cessions, rapprochements et joint-ventures dans un large éventail d’industries et est intervenu au cours des dernières années sur des opérations internationales impliquant des clients ou des cibles situées dans de nombreux pays.
Results
Equity Capital Markets Transactions
- Advised Genkyotex (France, Euronext Paris) on its rights issue
- Advised GeNeuro (Switzerland, Euronext Paris) on its international offering of new shares
- Advised Aerkomm, Inc. (US, OTCQX) on the initial listing of its shares on Euronext Paris*
- Advised Fosun Tourism Group (which owns Club Med) on its IPO and listing on the Main board of the Hong Kong Stock Exchange*
- Advised GeNeuro (Switzerland, Euronext Paris) on a corporate credit line granted by GNEH (Institut Mérieux)*
- Advised Genkyotex (Biotechnology, France, Euronext Paris) on two issuances of convertible bonds with warrants attached (OCABSA)*
- Advised Gilbert Dupont and KBC Securities, as underwriters, on the proposed IPO of a French medical device company on Euronext Paris*
- Advised Midcap and Oddo BHF, as underwriters, on the public offering of Wallix (Cyber, France, Euronext Paris)*
- Advised Dietswell (Oil and Gaz exploration services, France, Euronext Growth) on its private placement of new shares*
- Advised Gilbert Dupont and NIBC, as underwriters, on the IPO of Advicenne (Biotech, France) on Euronext Paris*
- Advised Symetis (Medical Device, Switzerland) and the underwriters (Bryan Garnier, Mirabaud and Baader), on Symetis’ proposed IPO and listing on Euronext Paris (which ended with Symetis acquisition by Boston Scientific)*
- Advised GenKyotex (Biotech, Switzerland) on its reverse acquisition of Genticel (Euronext Paris and Brussels) by way of a contribution in kind remunerated in newly issued Genticel shares listed on Euronext Paris and Brussels*
- Advised GeNeuro (Biotech, Switzerland) and the underwriters (Société Générale and Bryan Garnier) on GeNeuro’s IPO on Euronext Paris*
- Advised Kempen, as underwriter, on the issuance and international private placement of Nanobiotix’ (Biotech, France, Euronext Paris) shares*
- Advised a French provider of serialization software solutions on its proposed IPO and listing on Euronext Paris (postponed after filing with the AMF)*
- Advised Société Générale and Kempen, as underwriters, on the IPO and dual listing of Mainstay Medical (Medical Device, Ireland) on Euronext Paris and the Irish Stock Exchange*
- Advised Eren Group on the IPO of Orège (Cleantech, France) on Euronext Paris*
- Advised L’Occitane (Cosmetics, Luxembourg/France) on its IPO on the Hong Kong Stock Exchange*
- Advised the underwriters on the IPO of Helikos (SPAAC of Wendel) on Deutsche Börse*
- Advised Heidelberg Cement (Germany) on the “re-IPO” international offering of 35% of the shares of Vicat (Cement, France, Euronext Paris) held by Heidelberg Cement*
- Advised UBS and Merrill Lynch, as underwriters on the projected IPO of HBM Bioventures (Life Science investment, Switzerland) on SWX (postponed after filing with the securities regulator)*
- Advised Merrill Lynch and Natixis, as underwriters, on Novagali Pharma’s (Biotech, France) IPO project on Euronext Paris (postponed after initial filing with the AMF)*
- Advised Doughty Hanson (Private Equity fund) on its projected IPO on Euronext Amsterdam (postponed after initial filing with Dutch AFM)*
- Advised LCF Edmond de Rothschild (Banking and asset management, France) on its projected IPO on Euronext Paris (postponed after initial filing with the AMF)*
- Advised Morgan Stanley and Calyon, as underwriters, on the projected IPO of Resico (Gecina’s residential real estate spin-off, France) on Euronext Paris (postponed after initial filing with the AMF)*
- Advised ING and Bryan Garnier, as underwriters, on the IPO of Bioalliance Pharma (Biotech, France) on Euronext*
- Advised Wendel, as main shareholder, on the IPO of Legrand (Electrical infrastructures) on Euronext Paris*
- Advised NetCentrex (Telecom IP Equipement, France) on its projected IPO on Euronext Paris (postponed after initial filing with the AMF and its sale to Comverse)*
- Advised Saft (Batteries, France) on its IPO on Euronext Paris*
- Advised Iliad (Holding company of Free, Telecom, France) on its IPO on Euronext Paris*
- Advised UBS, acting as underwriter on IDM’s (Biotech, France) projected IPO on Euronext Paris (postponed after initial filing with the AMF)*
- Advised the underwriters on Air France-KLM (Airline, France, Euronext Paris) on its privatization and international secondary offering of shares*
- Advised Morgan Stanley, BNPP, JP Morgan, SG, ABN Amor Rothschild and Merrill Lynch, as underwriters on the privatization and international secondary share offering of France Telecom (Telecom, France, Euronext Paris)*
- Advised HSBC, Lehman Brothers and Société Générale, as underwriters, on the privatization and IPO of Autoroutes Paris-Rhin-Rhône (Toll road operator, France) on Euronext Paris*
- Advised Société Générale and CSFB, as underwriters, on the privatization and international secondary share offering of Dassault Systèmes (Software, France, Euronext Paris)*
- Advised HSBC and Credit Lyonnais, as underwriters, on the privatization and IPO of Autoroutes du Sud de la France (Toll road operator, France)*
- Advised ABN-AMRO Rothschild, JPMorgan, BNP and Credit Agricole Indosuez, as underwriters on Bacou-Dalloz’ (Protection Gear, France) “re-IPO” rights issue*
- Advised Société Générale and Cazenove, acting as underwriters, Memscap’s (MEMS Technology, France) IPO and listing on Euronext Paris*
- Advised as underwriters on EADS NV (Aerospace, The Netherlands) IPO and listing on Euronext Paris, Madrid Stock Exchange and Euronext Paris*
- Advised Aerospatiale Matra (Aerospace, France) on its privatization and IPO (Euronext Paris)*
- Advised Riber (Semiconductors equipments, France) on its IPO and listing on Euronext Paris*
- Advised Bank Hapoalim (Banking, Israel) on its IPO and international offering (London Stock Exchange)*
Other Securities Offerings (equity secondary offerings, rights issues, private placements, PIPEs, convertible bonds)
- Advised on behalf of issuers or underwriters on equity and equity-linked securities offerings of GeNeuro, Genkyotex, Dietswell, Wallix, LBC Terminals, Orchestra, Soitec, Ingenico, Alcatel-Lucent, Saft, Cegedim, SIIC de Paris, Imerys, Hammerson, Faiveley, Steria, Cesar, Rhodia, Société de la Tour Eiffel, France Telecom, Studio Canal, Medidep, Havas Advertising, Orchestra-Kazibao, and Lafarge*
Mergers and acquisitions
- Advised Alcatel (France, Euronext Paris) on its USD 13.5 billion merger with Lucent Technologies (NYSE)*
- Advised Fonds Stratégique d’Investissement (France) on its PIPE in Cegedim (Healthcare digital data services, France, Euronext Paris)*
- Advised Ubisoft (Gaming, France, Euronext Paris) on various M&A and corporate governance matter*
- Advised GenKyotex (Biotech, Switzerland) on its reverse acquisition of Genticel (Euronext Paris and Brussels)*
- Advised KWS SAAT (Plant breeding, Germany, Börse Frankfurt) on its acquisition of French company Momont, and the creation of Gemstar, a French joint venture with Vilmorin (Euronext Paris)*
- Advised Qualcomm (Nasdaq) on its strategic alliance with Alcatel-Lucent (Technology, Euronext Paris) and its acquisition of up to four tranches of existing Alcatel-Lucent treasury shares*
- Advised Faurecia (Automotive, France, Euronext Paris) on the acquisition of Sora Composites and on the acquisitions of selected operations of Borgers and Mecaplast*
- Advised SIIC de Paris (Real Estate, France, Euronext Paris) and its Spanish shareholder Realia on the 30% contribution by Société Foncière Lyonnaise (Real Estate, Euronext Paris) in SIIC de Paris*
- Advised Compagnie Financière Edmond de Rothschild (Banking and asset management, France) on its strategic partnership with Bank of China and Bank of China’s proposed 20% minority investment in LCFR*
- Advised Carlson Wagonlit Travel (Professional Travel, France) on the creation of a common network with Groupe Nouvelles Frontières under the brand Havas Voyages*
- Advised General Dynamics, Inc. (Aerospace and Defense, U.S., NYSE) on its acquisition of the French operations of Axletech Inc.*
- Advised GE Real Estate (Real Estate, France) on its buy-out tender offer on IPBM (REIT, Euronext Paris)*
- Advised Eren Group (Investment fund, France) in relation to its acquisition of a 25% stake in Orege (Euronext Paris) in connection with its IPO*
- Advised Alcatel-Lucent (Technology, France, Euronext Paris) on the restructuring of NextiraOne*
- Advised Holmarcom (Investment company, Morocco) on the the Joint Venture of Regional Airlines with Air Arabia (Air Arabia Maroc)*
*Handled prior to joining McDermott
Distinctions
- Legal 500 Paris, Capital market: Equity, 2008-2019
- IFLR 1000, Capital Markets: Equity, M&A, 2008-2020
- Best Lawyers, Capital markets Law, 2009-2021
- Chambers Europe (2006-2012, 2018) and Chambers Global (2007-2012, 2018)
- The Legal Media Group Expert Guides: Capital Markets (2008-2020)
Credentials
Education
Harvard Law School, Graduate Program, Fulbright Scholar, 1997-1998
University of Paris I (Panthéon-Sorbonne), Master’s degree in Business Law (Magistère), 1996
University of Paris I (Panthéon-Sorbonne), Master’s degrees in Public Law (DEA), 1996
University of Paris I (Panthéon-Sorbonne), Master’s degrees in the History of International Relations (DEA), 1995
Admissions
Paris
Languages
English
French